Johnson & Johnson receives positive CHMP opinion for
This positive CHMP opinion establishes amivantamab as a new option, and the first fully-human EGFR-MET bispecific antibody, in the first-line treatment of...
Source: globenewswire.com
📰 Diverse Models News
Diverse Models News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Diverse Models. Real-time updates on events, politics, business and more.
Johnson & Johnson : Janssen Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of Lazertinib, in combination with RYBREVANT®▼ (amivantamab), for the First-Line Treatment of Patients with EGFR-Mutated Non-Small Cell Lung Cancer -December 21, 2023 at 08:44 am EST
News Release Media Contacts: Zayn Qureshi +44 7760 334666 Email: zqureshi@its.jnj.com Investor...
Region Flamande United States Catherine Taylor Kiran Patel Zayn Qureshi Janssen Research Development
Source: marketscreener.com
Landmark Phase 3 MARIPOSA Study Shows
Early data show an overall survival trend favoring the combination of amivantamab and lazertinib compared to osimertinib; consistent results seen in...
Source: globenewswire.com
Rombo Picks Review: Striking the Perfect Chord Between Quality and Innovation
Based in Stuttgart, Germany, Rombo Picks is a small, two-person business led by Carlos Diez Macia and Judith Heindorf.
Source: bassmusicianmagazine.com
New Long-Term Data from the CHRYSALIS Study Show Median
Further analyses from the Phase 1/1b CHRYSALIS-2 study showed patients with osimertinib pre-treated EGFR-mutated lung cancer who have a MET positive...
Source: globenewswire.com
IHG continues to lead booming business travel market in greater china with diversified investment initiatives : Tuesday, 23rd May 2023 : 4Hoteliers
With the continuous recovery of domestic tourism in China, the demand for business and MICE travel has surged.Responding
Source: 4hoteliers.com
IHG continues to lead booming business travel market in greater china with diversified investment initiatives
With the continuous recovery of domestic tourism in China, the demand for business and MICE travel has surged. Responding to this market growth, IHG Hotels & Resorts launched its 2023 IHG Greater China Expo & Owner Roadshow with the theme of "Go Beyond", hosting events in Shenzhen, Shanghai, and Beijing to showcase the company’s robust development in the business travel market.
Source: hospitalitynet.org
'Your diversity doesn't count': Levi's AI models prompt anger, but the denimwear label says they're not a substitute for real action
Levi’s has been criticised for using AI as a replacement for hiring diverse models, but the denimwear label says it does not regard AI models as a substitute for real action on diversity.
Source: scmp.com
Janssen EMEA Receives Conditional Marketing Authorisation for RYBREVANT ? (amivantamab), the First Treatment Approved for Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations...
For EU Trade and Medical Media Only. Not to Be Distributed to UK and Benelux Based Media Conditional Marketing Authorisation is based on results from the Phase 1 CHRYSALIS study evaluating amivantamab
Source: finanznachrichten.de
Janssen Receives Positive CHMP Opinion for RYBREVANT (amivantamab) for the Treatment of Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations After Failure of Platinum-Based Therapy
If approved by the European Commission, amivantamab will be the first treatment in the European Union specifically targeting EGFR exon 20 insertion mutations for advanced non-small cell lung cancer
Source: finanznachrichten.de